Physician profile
Jack Zuckerman
NPI 1508093428
$2,160.05
in general payments reported to CMS, 2019-2025
15 companies · $152 in 2025
The $152 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $221 · 2021: $82.09 · 2022: $251 · 2023: $811 · 2024: $643 · 2025: $152.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,606.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,606.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $890.26 | 2021-2024 | Urolift |
| Boston Scientific Corporation | $552.38 | 2019-2025 | Ams 700, Rezum Generator |
| Axonics, INC. | $169.18 | 2022 | |
| Neotract INC. | $137.66 | 2019 | |
| Calyxo, INC. | $92.20 | 2024-2025 | Cvac Aspiration System |
| Laborie Medical Technologies Corp. | $66.79 | 2023-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Coloplast Corp | $63.37 | 2023 | Speedicath |
| Endo Pharmaceuticals INC. | $47.71 | 2023 | Aveed, Xiaflex, Edex |
| Ferring Pharmaceuticals INC. | $37.01 | 2024 | Adstiladrin |
| Dendreon Pharmaceuticals LLC | $22.39 | 2019 | |
| Photocure INC | $21.39 | 2023 | Cysview |
| Medtronic, INC. | $20.08 | 2021 | |
| Endo USA, INC. | $18.04 | 2024 | Xiaflex |
| Abbvie INC. | $15.84 | 2024 | |
| Valencia Technologies Corporation | $5.75 | 2025 | Ecoin Device Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jack Zuckerman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.